Article Detail - JE Part B
MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer (L39005) - R1 - Effective July 27, 2023
This Local Coverage Determination (LCD) has been revised under contractor numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, and NMI), and 01312 (NV).
Medicare Coverage Database (MCD) Number: L39005
Effective Date: July 27, 2023
Summary of Changes: Under CMS National Coverage Policy updated section headings. Under Bibliography revised Source #27 to remove broken hyperlink and changes were made to citation to reflect AMA citation guidelines. Formatting, punctuation, and typographical errors were corrected throughout the LCD. Acronyms were inserted where appropriate throughout the LCD.
Visit the Active LCDs webpage to view the Active LCD or access it via the CMS MCD.